In the “days BC (before cancer)”, Jess BeCraft was a self-proclaimed DINK (dual income, no kids). A career-driven, world-traveling, Chicago-loving woman, Jess and her husband decided a little over three years ago that they were ready to start a family. “We knew life would dramatically change,” Jess said. “But we had no idea just how … Continued
The novel coronavirus pandemic has impacted the healthcare system on every level. Right now, OCRA is working alongside several cancer advocacy groups to ensure government agencies are aware of COVID-19’s real-life impact on cancer patients. If you’re currently undergoing treatment for ovarian cancer, please take a moment to complete the form below. Sharing your experience … Continued
(April 15) The novel coronavirus, COVID-19, has become nearly all consuming. It’s impossible to turn on the news, browse social media, or walk outside without being reminded of the new, albeit temporary, state of the world. In an effort to control, slow, and hopefully stop the spread of COVID-19, drastic public health measures have been … Continued
There are many adjectives one can use to describe ovarian cancer: relentless, cruel, a monster. But Dr. Sunila Pradeep also finds it ironic. “Women spend a lot of time and energy for the next generation. They are playing a major role in continuing life on earth. And then when many of them have fulfilled those … Continued
OCRA is committed to offering patients, caregivers and friends the most up to date information about ovarian cancer, helpful resources, and options for support. Below are some helpful links, and you can find even more information throughout our website. Patient Support Line Our Patient Support team is available Monday through Friday to provide support, information … Continued
Friends, I hope this finds you well, or as well as can be expected during this challenging time. My wish for all of you is that you are feeling safe, and surrounded by caring community. If there was a silver lining to a global pandemic — and I struggle to say that there is, but … Continued
As we remain steadfast in our long-range mission of being the voice for the ovarian cancer community and funding life-saving research, we also want to acknowledge the moment we are in now. We know that the isolation required of all of us may be both familiar to those who are undergoing or have gone through … Continued
She has swum in the Amazon, gone ice fishing in the Arctic, traveled the Galapagos, and hang-glided in New Zealand. But the biggest trail Dr. Beth Karlan has blazed throughout her life has been in the field of gynecologic oncology. Dr. Karlan is Professor and Vice Chair of Women’s Health Research in the Department of … Continued
(March 13, 2020) As a global charity, we recognize the extraordinarily stressful times we as a society are all in together. We have taken every precaution to protect OCRA staff as they continue to do their jobs (remotely) in our collective fight against ovarian cancer. And if you have ovarian cancer and are concerned about … Continued
Dr. Ron Buckanovich, an OCRA grantee, uses a metaphor to describe his work. “If I’m trying to get into Chicago and the highways that get me into the city are blocked off, no matter how important my job is, I’m not going to get there.” He’s talking about immunotherapy and the fact that the cells … Continued
Are you an ovarian cancer survivor, patient, or caregiver? Don’t miss YOUR chance to learn what’s new in ovarian cancer treatments and research, and to meet others in the ovarian cancer community. Early Bird Registration is open! OCRA’s Ovarian Cancer National Conference® brings together people from across the country for a weekend of informative presentations, … Continued
(February 13, 2020) PARP inhibitors have shown to be a promising treatment option for a subset of ovarian cancer patients. As of February 2020, there are currently 3 FDA-approved PARP inhibitors for ovarian cancer: olaparib (Lynparza), niraparib (Zejula), and rucaparib (Rubraca). In an interview with OncLive, Dr. Robert Coleman, a member of OCRA’s Scientific Advisory … Continued
Get email updates about research news, action alerts, and ways to join the fight.
